UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1769) 1769
carmustine - administration & dosage (1606) 1606
male (1264) 1264
female (1262) 1262
science & technology (1138) 1138
life sciences & biomedicine (1121) 1121
middle aged (1032) 1032
adult (996) 996
antineoplastic combined chemotherapy protocols - therapeutic use (925) 925
biological and medical sciences (855) 855
medical sciences (843) 843
oncology (696) 696
aged (626) 626
pharmacology. drug treatments (577) 577
chemotherapy (557) 557
combined modality therapy (545) 545
antineoplastic agents (544) 544
animals (526) 526
cyclophosphamide - administration & dosage (512) 512
carmustine - therapeutic use (508) 508
brain neoplasms - drug therapy (455) 455
melphalan - administration & dosage (418) 418
etoposide - administration & dosage (401) 401
carmustine - adverse effects (400) 400
antineoplastic combined chemotherapy protocols - adverse effects (364) 364
cytarabine - administration & dosage (349) 349
hematology (342) 342
antineoplastic combined chemotherapy protocols - administration & dosage (326) 326
treatment outcome (318) 318
adolescent (313) 313
vincristine - administration & dosage (311) 311
transplantation, autologous (295) 295
abridged index medicus (277) 277
mice (273) 273
cisplatin - administration & dosage (270) 270
glioma - drug therapy (257) 257
carmustine (256) 256
doxorubicin - administration & dosage (231) 231
prognosis (226) 226
survival analysis (224) 224
prednisone - administration & dosage (222) 222
antineoplastic agents, alkylating - administration & dosage (220) 220
transplantation (219) 219
antineoplastic agents - administration & dosage (217) 217
survival rate (210) 210
bone marrow transplantation (207) 207
time factors (205) 205
hematopoietic stem cell transplantation (200) 200
drug therapy, combination (196) 196
glioblastoma - drug therapy (191) 191
rats (191) 191
carmustine - pharmacology (189) 189
disease-free survival (188) 188
neurosciences & neurology (188) 188
cancer (175) 175
clinical neurology (174) 174
drug administration schedule (165) 165
follow-up studies (164) 164
dose-response relationship, drug (162) 162
remission induction (160) 160
retrospective studies (160) 160
dacarbazine - administration & dosage (152) 152
antineoplastic agents - therapeutic use (145) 145
immunology (141) 141
bcnu (140) 140
hodgkin disease - drug therapy (133) 133
multiple myeloma - drug therapy (131) 131
medicine & public health (128) 128
neurology (128) 128
hodgkin disease - therapy (126) 126
combined treatments (120) 120
brain neoplasms - radiotherapy (119) 119
child (117) 117
prospective studies (116) 116
antineoplastic agents, alkylating - therapeutic use (115) 115
melanoma - drug therapy (115) 115
pharmacology & pharmacy (115) 115
clinical trials as topic (114) 114
lymphoma, non-hodgkin - drug therapy (111) 111
care and treatment (110) 110
lymphoma, non-hodgkin - therapy (110) 110
recurrence (109) 109
tumors (109) 109
brain neoplasms - surgery (108) 108
stem cells (108) 108
brain neoplasms - pathology (107) 107
methotrexate - administration & dosage (107) 107
dexamethasone - administration & dosage (105) 105
hematologic and hematopoietic diseases (101) 101
surgery (101) 101
carmustine - toxicity (100) 100
biophysics (99) 99
brain neoplasms - therapy (99) 99
neoplasm transplantation (99) 99
podophyllotoxin - administration & dosage (98) 98
fluorouracil - administration & dosage (97) 97
brain neoplasms - mortality (95) 95
drug evaluation (94) 94
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (93) 93
cyclophosphamide - therapeutic use (91) 91
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2130) 2130
German (24) 24
Japanese (22) 22
Russian (21) 21
Spanish (20) 20
French (17) 17
Chinese (10) 10
Polish (9) 9
Italian (6) 6
Czech (2) 2
Danish (1) 1
Hebrew (1) 1
Hungarian (1) 1
Lithuanian (1) 1
Portuguese (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The lancet oncology, ISSN 1470-2045, 08/2017, Volume 18, Issue 8, pp. 1076 - 1088
Journal Article
British journal of haematology, ISSN 0007-1048, 05/2014, Volume 165, Issue 4, pp. 534 - 544
refractory disease | relapse | children | survival | Hodgkin lymphoma | Relapse | Children | Refractory disease | Survival | Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Procarbazine - administration & dosage | Prednisolone - adverse effects | Recurrence | Cyclophosphamide - administration & dosage | Prednisolone - administration & dosage | Follow-Up Studies | Humans | Vinblastine - administration & dosage | Cyclophosphamide - adverse effects | Hodgkin Disease - surgery | Hodgkin Disease - mortality | Vincristine - administration & dosage | Child | Dacarbazine - administration & dosage | Dexamethasone - administration & dosage | Hematopoietic Stem Cell Transplantation | Etoposide - administration & dosage | Combined Modality Therapy | Bleomycin - administration & dosage | Remission Induction | Cytarabine - administration & dosage | Ifosfamide - administration & dosage | Adolescent | Vincristine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Epirubicin - administration & dosage | Cisplatin - administration & dosage | Hodgkin Disease - radiotherapy | Multicenter Studies as Topic | Hodgkin Disease - drug therapy | Retrospective Studies | Radiotherapy, Adjuvant | Doxorubicin - administration & dosage | Chlorambucil - administration & dosage | Prednisone - administration & dosage | Etoposide - adverse effects | Ifosfamide - adverse effects | Kaplan-Meier Estimate | Treatment Outcome | Clinical Trials as Topic | Disease-Free Survival | Melphalan - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cisplatin - adverse effects | Neoplasm Staging | Doxorubicin - adverse effects | Carmustine - administration & dosage | Patient outcomes | Diseases | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 05/2012, Volume 119, Issue 20, pp. 4619 - 4624
Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Podophyllotoxin - adverse effects | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Dexamethasone - adverse effects | Male | Transplantation, Autologous | Cytarabine - adverse effects | Cisplatin - administration & dosage | Young Adult | Lymphoma, Large B-Cell, Diffuse - therapy | Melphalan - adverse effects | Immunotherapy | Treatment Failure | Podophyllotoxin - administration & dosage | Adult | Female | Chemotherapy, Adjuvant | Carmustine - adverse effects | Genes, myc - physiology | Dexamethasone - administration & dosage | Etoposide - adverse effects | Lymphoma, Large B-Cell, Diffuse - drug therapy | Ifosfamide - adverse effects | Rituximab | Etoposide - administration & dosage | Combined Modality Therapy | Cytarabine - administration & dosage | Lymphoma, Large B-Cell, Diffuse - mortality | Melphalan - administration & dosage | Ifosfamide - administration & dosage | Cisplatin - adverse effects | Aged | Hematopoietic Stem Cell Transplantation - methods | Antibodies, Monoclonal, Murine-Derived - adverse effects | Lymphoma, Large B-Cell, Diffuse - genetics | Carmustine - administration & dosage | Index Medicus | Abridged Index Medicus | Life Sciences | Biochemistry, Molecular Biology | Lymphoma, Large B-Cell, Diffuse | Podophyllotoxin | methods | Genes, myc | Cytarabine | genetics | administration & dosage | Melphalan | Antibodies, Monoclonal, Murine-Derived | Dexamethasone | drug therapy | Ifosfamide | Carmustine | therapy | Antineoplastic Combined Chemotherapy Protocols | Etoposide | physiology | Hematopoietic Stem Cell Transplantation | Cisplatin | adverse effects | mortality
Journal Article
European journal of haematology, ISSN 0902-4441, 03/2010, Volume 84, Issue 3, pp. 266 - 270
dexamethasone | refractory disease | cyclophosphamide | thalidomide | transplantation | Hodgkin's lymphoma | Cyclophosphamide | Transplantation | Dexamethasone | Refractory disease | Thalidomide | Life Sciences & Biomedicine | Hematology | Science & Technology | Procarbazine - administration & dosage | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prednisolone - administration & dosage | Humans | Salvage Therapy | Drug Resistance, Neoplasm | Male | Transplantation, Autologous | Vinblastine - administration & dosage | Hodgkin Disease - surgery | Cisplatin - administration & dosage | Hodgkin Disease - radiotherapy | Organoplatinum Compounds - administration & dosage | Hodgkin Disease - drug therapy | Vincristine - administration & dosage | Adult | Paclitaxel - administration & dosage | Doxorubicin - administration & dosage | Dacarbazine - administration & dosage | Prednisone - administration & dosage | Antibodies, Monoclonal, Murine-Derived | Dexamethasone - administration & dosage | Deoxycytidine - administration & dosage | Rituximab | Etoposide - administration & dosage | Combined Modality Therapy | Vidarabine - analogs & derivatives | Bleomycin - administration & dosage | Thalidomide - administration & dosage | Remission Induction | Cytarabine - administration & dosage | Melphalan - administration & dosage | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Topotecan - administration & dosage | Mechlorethamine - administration & dosage | Vidarabine - administration & dosage | Peripheral Blood Stem Cell Transplantation | Deoxycytidine - analogs & derivatives | Carmustine - administration & dosage | Antimitotic agents | Stem cells | Antineoplastic agents | Hodgkin's disease | Steroids | Index Medicus
Journal Article
Journal Article
Blood, ISSN 0006-4971, 11/2008, Volume 112, Issue 10, pp. 4017 - 4023
Journal Article
British journal of haematology, ISSN 0007-1048, 08/2012, Volume 158, Issue 3, pp. 355 - 362
Journal Article
Blood, ISSN 0006-4971, 11/2001, Volume 98, Issue 10, pp. 2930 - 2934
Biological and medical sciences | Radionuclide investigations | Investigative techniques, diagnostic techniques (general aspects) | Medical sciences | Blood cells | Hodgkin Disease - diagnostic imaging | Procarbazine - administration & dosage | Predictive Value of Tests | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Follow-Up Studies | Hodgkin Disease - pathology | Humans | Salvage Therapy | Transplantation, Autologous | Life Tables | Vinblastine - administration & dosage | False Positive Reactions | Mediastinal Neoplasms - therapy | Hodgkin Disease - mortality | Vincristine - administration & dosage | Radiopharmaceuticals | Radiotherapy, Adjuvant | Doxorubicin - administration & dosage | Dacarbazine - administration & dosage | Diagnosis, Differential | Prednisone - administration & dosage | Dexamethasone - administration & dosage | False Negative Reactions | Hematopoietic Stem Cell Transplantation | Etoposide - administration & dosage | Combined Modality Therapy | Neoplasm Recurrence, Local - diagnosis | Bleomycin - administration & dosage | Mediastinal Neoplasms - diagnostic imaging | Remission Induction | Cytarabine - administration & dosage | Disease-Free Survival | Melphalan - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mediastinal Neoplasms - pathology | Hodgkin Disease - therapy | Fibrosis | Fluorodeoxyglucose F18 | Tomography, Emission-Computed | Carmustine - administration & dosage | Index Medicus | Abridged Index Medicus
Journal Article
Annals of oncology, ISSN 0923-7534, 5/2008, Volume 19, Issue 5, pp. 958 - 963
Autologous stem-cell transplantation | Peripheral T-cell lymphoma | Prognosis | Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Transplantation, Autologous | Cytarabine - adverse effects | Cyclophosphamide - adverse effects | Cisplatin - administration & dosage | Vincristine - administration & dosage | Adult | Female | Lymphoma, T-Cell, Peripheral - classification | Doxorubicin - administration & dosage | Lymphoma, T-Cell, Peripheral - drug therapy | Prednisone - administration & dosage | Etoposide - adverse effects | Prednisone - adverse effects | Etoposide - administration & dosage | Treatment Outcome | Combined Modality Therapy | Remission Induction | Cytarabine - administration & dosage | Neoplasms, Second Primary - epidemiology | Disease-Free Survival | Melphalan - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cisplatin - adverse effects | Vincristine - adverse effects | Lymphoma, T-Cell, Peripheral - surgery | Aged | Transplantation Conditioning | Peripheral Blood Stem Cell Transplantation | Doxorubicin - adverse effects | Carmustine - administration & dosage | Index Medicus
Journal Article